Recent progress in the treatment of advanced prostatic cancer.
Prostatic cancer is the second most common cause of male cancer-related deaths in the UK. Its incidence has almost doubled over the last 30 years, and this may relate to lifestyle, diet, and environmental factors, and far exceeds the changes expected from demographic trends and increased diagnosis.
Saini
A
A
Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Waxman
J
J
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D015994:Incidence; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D011878:Radiotherapy; D006113:United Kingdom / Q000453:epidemiology
D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone; D004054:Diethylstilbestrol